切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2016, Vol. 05 ›› Issue (05) : 386 -389. doi: 10.3877/cma.j.issn.2095-3224.2016.05.004

所属专题: 文献

专家论坛

结直肠癌肝转移影像诊断策略
邱大胜1,()   
  1. 1. 430079 湖北省肿瘤医院PET/CT中心
  • 收稿日期:2016-06-18 出版日期:2016-10-25
  • 通信作者: 邱大胜

Diagnostic imaging strategies for colorectal liver metastases

Dasheng Qiu1,()   

  1. 1. PET/CT Center, Hubei Cancer Hospital, Wuhan 430079, China
  • Received:2016-06-18 Published:2016-10-25
  • Corresponding author: Dasheng Qiu
  • About author:
    Corresponding author: Qiu Dasheng, Email:
引用本文:

邱大胜. 结直肠癌肝转移影像诊断策略[J]. 中华结直肠疾病电子杂志, 2016, 05(05): 386-389.

Dasheng Qiu. Diagnostic imaging strategies for colorectal liver metastases[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2016, 05(05): 386-389.

超声、CT、MRI、PET/CT及PET/MR在结直肠癌肝转移诊治中广泛应用,NCCN指南提出结直肠癌肝转移影像学诊断首选增强MR,但对于每个结直肠癌肝转移患者如何选择合适的影像学检查,充分合理地应用有限的资源是临床关注的重点。结合国内外文献及笔者多年的MDT经验,对于结直肠癌肝转移患者,在参照指南的基础上更要结合患者自身病情,由多学科专家讨论做出合理的影像诊断。

Ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography CT (PET/CT) and positron emission tomography MR (PET/MR) are widely used in the diagnosis and treatment of colorectal liver metastases (CRCLM). Contrast-enhanced MR was the first choice in diagnosis of CRCLM by NCCN guidline. But it is important to choose the appropriate imaging modalities for each patient with CRCLM, and rationally use the limited medical resource.Combined with the literature and the authors experience in MDT. On the basis of reference to guidline and combined the patient′s own conditions, it could made reasonable decisions by multidisciplinary experts discussion for patients with liver metastases from colorectal cancer.

图1 72y/F,直肠癌术后肝转移SIEMENS 3.0TMR成像仪,平扫、Gd-DTPA-增强及DWI,层厚6.5 mm,层间距0.5 mm。图1A、1B:T1WI(TR 120 ms,TE 2.46 ms),T2WI(TR 3000ms,TE 110ms),肝右后下段(VI段)可见两枚稍长T1稍长T2信号小结节,最大径分别为1.1 cm、0.7 cm;图1C:增强第VI较大结节呈环状强化,小结节增强强化不明显;图1D:DWI(TR 6700 ms,TE 93 ms,b=700 s/mm2)可见稍高信号结节(如白色箭头所示)
[1]
陈万清,郑荣寿,张思维.2012年中国恶性肿瘤发病及死亡分析[J]. 中国肿瘤, 2016, 25(11): 1-8.
[2]
Steele Jr,Ravikumar TS. Resection of hepatic metastases from colorectal cancer.Biologic perspective[J]. Ann Surg, 1989, 210(2): 127-138.
[3]
Rojas FL,Fabio FD,Ercolani G, et al. Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study[J]. British Journal of Cancer, 2014, 111(7): 667-673.
[4]
Legou F,Chiaradia M,Baranes L, et al. Imaging strategies before beginning treatment of colorectal liver metastases[J]. Diagnostic and interventional Imaging, 2014, 95(5): 505-512.
[5]
Tirumani SH,Kim KW,Nishino M, et al. Update on the Role of Imaging in Management of Metastatic Colorectal Cancer[J]. RadioGraphics, 2014, 34(7): 1908-1928.
[6]
Vincent SY,Brendan C,Declan FJ, et al. Optimal imaging sequence for staging in colorectal liver metastasese: Analysis of three hypothetical imaging strategies[J]. European Journal of Cancer, 2014, 50(5): 937-943.
[7]
Brismar TB,Kartalis N,Kylander C, et al. MRI of colorectal cancer liver metastases: comparison of orally administration manganese with intravebously administered gadobenate dimeglumine[J]. Eur radiol, 2012, 22(3): 633-641.
[8]
Power DG,Kemeny NE.Role of adjuvant therapy after resection of colorectal cancer liver metastases[J]. J Clin Oncol, 2010, 28(13): 2300-2309.
[9]
Kim HJ,Lee SS,Byun JH, et al. Incremental value of liver MRI in patients with potentially curable colorectal hepatic metastasis detected at CT: A prospective comparison of DWI, Gadoxetic acid-enhanced MRI , and a combination of both MR technique[J]. Radiology, 2015, 274(3): 712-722.
[10]
Bonanni L,de′Liguori Cainio N,Deshpande R, et al. A comparison of diagnostic imaging modalities for colorectal liver metastases[J]. Eur J Surg Oncol, 2014, 40(5): 545-550.
[11]
Koh DM,Collins DJ,Wallace T, et al. Combining diffusion-weighted MRI with Gd-EOB-DTPA enhanced MRI improves the detection of colorectal liver metastases[J]. The British Journal of Radiology, 2012, (85): 980-989.
[12]
Brendle C,Schwenzer NF,Rempp H, et al. Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series[J]. Eur J Nucl Med Mol Imaging, 2016, 43(1): 123-132.
[1] 李淼, 朱连华, 韩鹏, 姜波, 费翔. 高帧频超声造影评价肝细胞癌血管形态与风险因素的研究[J]. 中华医学超声杂志(电子版), 2023, 20(09): 911-915.
[2] 高建松, 陈晓晓, 冯婷, 包剑锋, 魏淑芳, 潘林. 基于超声瞬时弹性成像的多参数决策树模型评估慢性乙型肝炎患者肝纤维化等级[J]. 中华医学超声杂志(电子版), 2023, 20(09): 923-929.
[3] 丁建民, 秦正义, 张翔, 周燕, 周洪雨, 王彦冬, 经翔. 超声造影与普美显磁共振成像对具有高危因素的≤3 cm肝结节进行LI-RADS分类诊断的前瞻性研究[J]. 中华医学超声杂志(电子版), 2023, 20(09): 930-938.
[4] 韩丹, 王婷, 肖欢, 朱丽容, 陈镜宇, 唐毅. 超声造影与增强CT对儿童肝脏良恶性病变诊断价值的对比分析[J]. 中华医学超声杂志(电子版), 2023, 20(09): 939-944.
[5] 刘婷婷, 林妍冰, 汪珊, 陈幕荣, 唐子鉴, 代东伶, 夏焙. 超声衰减参数成像评价儿童代谢相关脂肪性肝病的价值[J]. 中华医学超声杂志(电子版), 2023, 20(08): 787-794.
[6] 吕衡, 董理聪, 谢海琴, 赵卓非, 刘俐, 孙德胜. 基于CT-超声对照的肝脏局灶性病变超声漏诊状况分析:一项单中心横断面质量控制调查报告[J]. 中华医学超声杂志(电子版), 2023, 20(07): 712-716.
[7] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[8] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[9] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[10] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[11] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[12] 吴方园, 孙霞, 林昌锋, 张震生. HBV相关肝硬化合并急性上消化道出血的危险因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 45-47.
[13] 叶晓琳, 刘云飞, 庞明泉, 王海久, 任利, 侯立朝, 于文昊, 王志鑫, 樊海宁. 肝再生细胞来源及调控机制的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 96-99.
[14] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[15] 孔凡彪, 杨建荣. 肝脏基础疾病与结直肠癌肝转移之间关系的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(07): 818-822.
阅读次数
全文


摘要